Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 1/2 2Phase NA 1Phase 4 1Phase 1 1

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Spondylitis, Ankylosing 1Signs and Symptoms 1Lymphoma 1Breast Neoplasms 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 900Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Sulfasalazine × Clear all
NCT03847311 2025-01-09

Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients

University of Arizona

Phase 2 Completed
7 enrolled 8 charts
Breast

Breast Neoplasms, Signs and Symptoms

NCT06557330 2025-01-06

MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma

Fox Chase Cancer Center

Phase 2 Not yet recruiting
24 enrolled
Lymphoid

Lymphoma

NCT02456363 2015-05-28

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Chung Shan Medical University

Phase 2 Unknown
300 enrolled

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡